T1	Participants 42 78	adults with autism spectrum disorder
T2	Participants 696 712	TAU participants
T3	Participants 223 338	Adults with autism spectrum disorder were randomized to VR-JIT (n = 16) or treatment-as-usual (TAU) (n = 10) groups
